Cargando…
Prevention of Thromboembolic Events in Patients with COVID-19
Autores principales: | Warrior, Surbhi, Behrens, Elizabeth, Thomas, Joshua, Gezer, Sefer, Venugopal, Parameswaran, Jain, Shivi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463134/ https://www.ncbi.nlm.nih.gov/pubmed/34595386 http://dx.doi.org/10.1055/a-1576-6201 |
Ejemplares similares
-
Heparin Induced Thrombocytopenia in Patients with COVID-19
por: Warrior, Surbhi, et al.
Publicado: (2020) -
Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020) -
Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020) -
Impact of Blood Group Type on Severity of Disease in COVID-19 Patients
por: Rao, Shivani, et al.
Publicado: (2020) -
Impact of blood type on thrombosis and disease severity in adult COVID-19 patients()
por: Rao, Shivani, et al.
Publicado: (2021)